Gabriel Adrian

5PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 11, 2026
External Validation of Pre-Treatment Primary Tumor Volume as a Prognostic Factor in Head and Neck Cancer Treated With (Chemo)Radiotherapy.

|Sep 08, 2023
Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors.

Gabriel Adrian, Maria Gebre-Medhin, Per Nilsson

|Jan 06, 2023
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response.

Claire M Storey, Mohamed Altai, Mesude Bicak

|Sep 09, 2022
Comment on Russo et al. Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis. Cancers 2022, 14, 2465.

Gabriel Adrian

|Mar 21, 2020
Altered fractionation diminishes importance of tumor volume in oropharyngeal cancer: Subgroup analysis of ARTSCAN-trial.

Gabriel Adrian, Maria Gebre-Medhin, Elisabeth Kjellén

Pageof 1

Frequent Collaborators

2 joint publications

Per Nilsson

1 joint publications

Claire M Storey

1 joint publications

Mohamed Altai

1 joint publications

Mesude Bicak